guest ::
| Home > Publications database > Adenoviral delivery of the CIITA transgene induces T‐cell‐mediated killing in glioblastoma organoids > print |
| Home > Publications database > Adenoviral delivery of the CIITA transgene induces T‐cell‐mediated killing in glioblastoma organoids > print |
| 001 | 294634 | ||
| 005 | 20250310103003.0 | ||
| 024 | 7 | _ | |a 10.1002/1878-0261.13750 |2 doi |
| 024 | 7 | _ | |a 1574-7891 |2 ISSN |
| 024 | 7 | _ | |a 1878-0261 |2 ISSN |
| 024 | 7 | _ | |a altmetric:170410117 |2 altmetric |
| 024 | 7 | _ | |a pmid:39535369 |2 pmid |
| 037 | _ | _ | |a DKFZ-2024-02378 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Salvato, Ilaria |0 0000-0002-9659-2703 |b 0 |
| 245 | _ | _ | |a Adenoviral delivery of the CIITA transgene induces T‐cell‐mediated killing in glioblastoma organoids |
| 260 | _ | _ | |a Hoboken, NJ |c 2025 |b John Wiley & Sons, Inc. |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1741598958_25932 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2025 Mar;19(3):682-697 |
| 536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de |
| 700 | 1 | _ | |a Klein, Eliane |b 1 |
| 700 | 1 | _ | |a Poli, Aurélie |b 2 |
| 700 | 1 | _ | |a Rezaeipour, Mahsa |b 3 |
| 700 | 1 | _ | |a Ermini, Luca |b 4 |
| 700 | 1 | _ | |a Nosirov, Bakhtiyor |b 5 |
| 700 | 1 | _ | |a Lipsa, Anuja |b 6 |
| 700 | 1 | _ | |a Oudin, Anaïs |b 7 |
| 700 | 1 | _ | |a Baus, Virginie |b 8 |
| 700 | 1 | _ | |a Dore, Gian Mario |b 9 |
| 700 | 1 | _ | |a Cosma, Antonio |b 10 |
| 700 | 1 | _ | |a Golebiewska, Anna |b 11 |
| 700 | 1 | _ | |a Marchini, Antonio |0 P:(DE-He78)2c1968abb9781c0328997892355fa74c |b 12 |u dkfz |
| 700 | 1 | _ | |a Niclou, Simone P. |0 0000-0002-3417-9534 |b 13 |
| 773 | _ | _ | |a 10.1002/1878-0261.13750 |g p. 1878-0261.13750 |0 PERI:(DE-600)2322586-5 |n 3 |p 682-697 |t Molecular oncology |v 19 |y 2025 |x 1574-7891 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:294634 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)2c1968abb9781c0328997892355fa74c |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b MOL ONCOL : 2022 |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-01-06T16:01:33Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-01-06T16:01:33Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Open peer review |d 2023-01-06T16:01:33Z |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2023-01-06T16:01:33Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-25 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-25 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-25 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b MOL ONCOL : 2022 |d 2023-10-25 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-10-25 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-10-25 |
| 920 | 1 | _ | |0 I:(DE-He78)D490-20160331 |k D490 |l KKE Virotherapie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)D490-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|